A clinical trial has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma […]

European Medicines Agency will consider therapy for the treatment of patients with multiple myeloma

AstraZeneca trial will study activity of AZD5156 which includes monoclonal antibody discovered by RQ Bio

Updated Date: Tue, 27 Dec 2022 00:00:00 EST

Updated Date: Tue, 27 Dec 2022 00:00:00 EST

Updated Date: Tue, 27 Dec 2022 00:00:00 EST

Updated Date: Tue, 27 Dec 2022 00:00:00 EST

Updated Date: Tue, 27 Dec 2022 00:00:00 EST

Company has reported booster details from a study of its inactivated COVID-19 candidate

Second study will develop a bispecific antibody with potential applications in solid tumours